AlgaeCytes

Kent, United Kingdom Founded: 2010 • Age: 16 yrs
Omega 3 oils and bio-actives are manufactured from freshwater algae.

About AlgaeCytes

AlgaeCytes is a Healthcare company based in United Kingdom founded in 2010. Omega 3 oils and bio-actives are manufactured from freshwater algae. AlgaeCytes has raised $5.73 million across 2 funding rounds from investors including IBG Beteiligungsgesellschaft Sachsen-Anhalt, BMWK and Germany Trade & Invest. The company has 12 employees. Its chief executive, as recorded, is Naz Bashir. AlgaeCytes offers products and services including Omega-3 EPA and Agricultural Biostimulant. Its focus areas include Life Sciences, Nutraceuticals Tech, Functional Foods and Beverages and Food Additives. Its legal entity is ALGAECYTES LIMITED.

Company details

AlgaeCytes was founded in 2010 and is based in Kent, United Kingdom. Operations center on the production of omega 3 oils and bio-actives derived from freshwater algae. These products are supplied to the healthcare, personal care, and nutraceuticals sectors. The focus remains on sustainable sourcing and processing for industrial applications in these markets.

  • Headquarters Kent, United Kingdom
  • Employees 12
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website algaecytes.com
  • Social LinkedIn
  • Legal Name Algaecytes Limited
  • Date of Incorporation 25 May, 2010
  • Jurisdiction CANTERBURY, KENT
Key Metrics

Products & Services of AlgaeCytes

AlgaeCytes offers a comprehensive portfolio of products and services, including Omega-3 EPA and Agricultural Biostimulant.

Omega-3 EPA
Nutritional Ingredient

Algae-derived Omega-3 for dietary supplements and health products

Agricultural Biostimulant
Agricultural Product

Enhances crop growth using sustainable algae-based compounds

Funding Insights of AlgaeCytes

AlgaeCytes has successfully raised a total of $5.73M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $12.6 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $5.73M
  • Total Rounds 2
  • Last Round Grant β€” $12.6M
  • First Round $5.73M

    (Jan 2022)

  • Investors Count 3

All 2 funding rounds of AlgaeCytes with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2022$5.73MSeries A––
Jan 2022$12.6MGrant––
Valuation history

3 investors in total: 3 institutional.

Investors in AlgaeCytes

AlgaeCytes has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include IBG Beteiligungsgesellschaft Sachsen-Anhalt, BMWK and Germany Trade & Invest.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
ibg-vc.de
bmwi.de
Germany Trade & Invest is focused on promoting international business expansion in Germany.
gtai.deBerlin, Germany
Premium access

Investor details for AlgaeCytes

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of AlgaeCytes

3 people are tracked at AlgaeCytes (2 in leadership, 1 in team); the tracked headcount is 12.

NameRoleGroup
Naz Bashir
CEOLeadership
Andrew Cosentino
CEOLeadership
Carolyn Spring
Office ManagerTeam
Premium access

Complete people profiles for AlgaeCytes

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of AlgaeCytes

2 dated milestones of AlgaeCytes across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded AlgaeCytes is founded.
  2. Funding First funding round of $5.7M.

Web traffic of AlgaeCytes

Websites that share an audience with AlgaeCytes (algaecytes.com).

Similar websites

Websites whose visitors overlap most with AlgaeCytes. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
zmsystems.co.uk
zmsystems.co.uk
100%
#7,739,025–
alienergy.org.uk
82%
2.2K#8,434,112View details
algae-uk.org.uk
algae-uk.org.uk
80%
–
deepbridgecapital.com
75%
#10,831,748View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about AlgaeCytes

AlgaeCytes was founded in 2010 and raised its 1st funding round 12 years after it was founded.

AlgaeCytes is headquartered in United Kingdom. It is registered at Kent, United Kingdom.

Naz Bashir is the CEO of AlgaeCytes, as recorded in our data.

AlgaeCytes is a funded company, having raised a total of $5.73M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5.73M, raised on Jan 2022.

AlgaeCytes has 12 employees.

AlgaeCytes was founded in 2010 and is based in Kent, United Kingdom. Operations center on the production of omega 3 oils and bio-actives derived from freshwater algae. These products are supplied to the healthcare, personal care, and nutraceuticals sectors. The focus remains on sustainable sourcing and processing for industrial applications in these markets.

AlgaeCytes offers Omega-3 EPA and Agricultural Biostimulant.

AlgaeCytes has 3 investors. Key investors include IBG Beteiligungsgesellschaft Sachsen-Anhalt, BMWK, and Germany Trade & Invest.

AlgaeCytes operates through Algaecytes Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available